Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 11/20 | 0.37 |
| ▸ | AURKA | O14965 | 2/20 | 0.34 |
| ▸ | ITK | Q08881 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | CACNA1G | O43497 | 2/20 | 0.33 |
| ▸ | CACNA1H | O95180 | 2/20 | 0.33 |
| ▸ | CACNA1I | Q9P0X4 | 2/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.33 |
| ▸ | LCK | P06239 | 1/20 | 0.32 |
| ▸ | TNKS2 | Q9H2K2 | 2/20 | 0.32 |
| ▸ | EEF2K | O00418 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | PARP1 | P09874 | 1/20 | 0.31 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL856160 | 0.86 | ACHE (0.35) | ACHEAURKAITKMAPK1CACNA1G | |
| SCHEMBL856115 | 0.86 | ACHE (0.36) | ACHEAURKAITKMAPK1LCK | |
| SCHEMBL857297 | 0.84 | AURKA (0.34) | ACHEAURKAITKMAPK1LCK | |
| SCHEMBL856241 | 0.84 | ACHE (0.33) | ACHEAURKAITKMAPK1LCK | |
| SCHEMBL857463 | 0.74 | AURKA (0.36) | ACHEAURKAITKMAPK1LCK | |
| SCHEMBL3717468 | 0.72 | ACHE (0.32) | ACHETNKS2EEF2K | |
| SCHEMBL856425 | 0.72 | ACHE (0.36) | ACHEMAPK1CACNA1GCACNA1HCACNA1I | |
| SCHEMBL858891 | 0.69 | TP53 (0.35) | ACHEAURKAITKMAPK1TNKS2 | |
| SCHEMBL3723441 | 0.67 | ACHE (0.35) | ACHEEEF2K | |
| SCHEMBL16460290 | 0.65 | ACHE (0.36) | ACHEEEF2K |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2432779-A1 | BENZOXAZEPINES BASED P13K/MT0R INHIBITORS AGAINST PROLIFERATIVE DISEASES | Exelixis, Inc. (US) | 2012-03-28 | — | — | EP | disclosed |